$CL · Colgate-Palmolive

Thesis

MDLZ template applies — Latam organic growth (CL's largest segment at ~25% of sales) offsets the FX-drag bear case, EPS comes in $0.97 vs Street $0.95, and reaffirm-guide on a name 15% below average PT reads as 'hidden levers' the way it did for MDLZ. Stock already pulled forward +2% on today's staples rotation, capping magnitude.

What would flip it

FX guide-down — if FY26 organic narrows or FX widens beyond 250bps, the EM-offset narrative cracks and stock fades.

The market's narrative

FX drag (~250bps headwind) and EM softness are the bear case; Latam pricing carryover and Hill's Pet are the bull case; staples bid into Friday open is mechanical.

Where the Street may be wrong

• MDLZ template applies directly — Latam organic strength (CL's largest segment, ~25% of sales) will offset FX headlines, exactly the EM-organic-offset pattern that flipped MDLZ -2.5% prediction to +4.95% actual.
• Hill's Pet category growing MSD with mix tailwind, Street modeling flat.

Peer read: MDLZ +4.95% on EM-organic-offsets-cost-pressure template — same setup applies to CL but Latam mix is ~25% of revenue here vs MDLZ's ~37%, so magnitude is muted.

Reasoning

• Independent EPS $0.97 vs Street $0.95 (+2.1%); rev $5.18B vs $5.21B (-0.6%) — EPS beat with FX-noise revenue miss.
• MDLZ lesson: cocoa-pressure miss thesis got flipped UP +4.95% on EM organic +6.3% offset + reaffirm-guide read as 'hidden levers' — CL has the same structural setup with Latam pricing carryover.
• Stock already up +2% intraday on staples rotation — partial pull-forward of the move.
• hype_neutral: 12/11/1 mix is balanced, no crowded long; risk-off rotation today is mechanical not thesis-driven.
• Reaffirm-guide on a name 15% below avg PT is a stealth-positive (opposite of AXP-style above-PT-reaffirm rule).